Cancer patients are at increased risk of developing venous thromboembolism (VTE).
Guidelines recommend routine thromboprophylaxis in hospitalised acutely ill cancer …

Venous thromboembolism (VTE) is a common complication in patients with cancer that
causes significant morbidity and mortality. Several patient-, tumour-and treatment-related …

Venous thromboembolism (VTE) is a major health problem among patients with cancer, its
incidence in this particular population is widely increasing. Although VTE is associated with …

BACKGROUND: Prevention of venous thromboembolism (VTE) in cancer patients remains
controversial in most clinical settings. PURPOSE: The Italian Society for Haemostasis and …

Patients with cancer are at increased risk of venous thromboembolism (VTE). In these
patients VTE is associated with substantial morbidity and complicates the clinical …

Patients with cancer are at increased risk of venous thromboembolism (vte). Anticoagulation
therapy has been shown to prevent vte; however, unique clinical circumstances in patients …

Cancer is a highly thrombophilic entity leading to a high rate of symptomatic and even
asymptomatic venous thromboembolic (VTE) events in patients suffering from malignant …

Venous thromboembolism (VTE) is a common event in cancer patients and one of the major
causes of cancer-associated mortality and a leading cause of morbidity. In recent years, the …

Venous thromboembolism (VTE) is a major public health issue [1] and one of the most
important causes of morbidity and mortality in cancer patients with a negative impact on their …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients
with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …